Literature DB >> 33751524

Cervical cancer screening in Poland in current SARS-CoV-2 pandemic: Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology - a summary January 2021.

Robert Jach1, Maciej Mazurec2, Martyna Trzeszcz3, Mariusz Zimmer4, Witold Kedzia5, Hubert Wolski6.   

Abstract

The Polish Society of Colposcopy and Cervical Pathophysiology (PTKiPSM) together with the Polish Society of Gynecologists and Obstetricians (PTGiP) issued a final summary of interim guidelines for secondary cervical cancer prevention during the SARS-CoV-2 pandemic based on the analysis of the latest directional publications and the authors' own experiences. The aim of the summary is to facilitate the implementation of the most effective possible screening of cervical precancerous lesions and cervical cancer due to temporary significant limitation of screening as a consequence of the ongoing epidemiological threat. These final guidelines are taking into account the 2020 call of the World Health Organization (WHO) for global epidemiological elimination of cervical cancer. The guidelines supplement the interim guidelines of PTKiPSM and PTGiP announced in March 2020 on the possible deferral of diagnostic and therapeutic procedures in patients with abnormal screening tests results in secondary prevention of cervical cancer in current pandemic.

Entities:  

Keywords:  HPV testing; SARS-CoV-2 pandemic; abnormal screening results; cervical cancer prevention; cervical cytology; guidelines; selfsampling

Mesh:

Year:  2021        PMID: 33751524     DOI: 10.5603/GP.2021.0043

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  6 in total

1.  Diagnosis Value of Colposcope Combined with Serum Squamous Cell Carcinoma Antigen, Carbohydrate Antigen 125, and Carcinoembryonic Antigen for Moderate to Advanced Cervical Cancer Patients Treated with Modified Fuzheng Peiyuan Decoction.

Authors:  Huijuan Meng; Yulan Zhang; Youguo Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-31       Impact factor: 2.629

Review 2.  Women's Healthcare Services since the COVID-19 Pandemic Outbreak in Poland.

Authors:  Katarzyna Wszołek; Dominik Pruski; Katarzyna Tomczyk; Małgorzata Kampioni; Karolina Chmaj-Wierzchowska; Marcin Przybylski; Maciej Wilczak
Journal:  Int J Environ Res Public Health       Date:  2021-12-24       Impact factor: 3.390

Review 3.  Thousands of Women's Lives Depend on the Improvement of Poland's Cervical Cancer Screening and Prevention Education as Well as Better Networking Strategies Amongst Cervical Cancer Facilities.

Authors:  Marcin Śniadecki; Patryk Poniewierza; Paulina Jaworek; Ada Szymańczyk; Gorm Andersson; Maria Stasiak; Michał Brzeziński; Małgorzata Bońkowska; Magdalena Krajewska; Joanna Konarzewska; Dagmara Klasa-Mazurkiewicz; Paweł Guzik; Dariusz Grzegorz Wydra
Journal:  Diagnostics (Basel)       Date:  2022-07-26

4.  The Application of Artificial Intelligence-Assisted Colposcopy in a Tertiary Care Hospital within a Cervical Pathology Diagnostic Unit.

Authors:  Aleksandra Zimmer-Stelmach; Jan Zak; Agata Pawlosek; Anna Rosner-Tenerowicz; Joanna Budny-Winska; Michal Pomorski; Tomasz Fuchs; Mariusz Zimmer
Journal:  Diagnostics (Basel)       Date:  2022-01-04

5.  A Six-Year Gynecological Follow-Up of Immunosuppressed Women with a High-Risk Human Papillomavirus Infection.

Authors:  Aleksandra Wielgos; Bronisława Pietrzak; Barbara Suchonska; Mariusz Sikora; Lidia Rudnicka; Miroslaw Wielgos
Journal:  Int J Environ Res Public Health       Date:  2022-03-16       Impact factor: 3.390

Review 6.  Organisation of cancer care in troubling times: A scoping review of expert guidelines and their implementation during the COVID-19 pandemic.

Authors:  Brenda Bogaert; Victoria Buisson; Zizis Kozlakidis; Pierre Saintigny
Journal:  Crit Rev Oncol Hematol       Date:  2022-03-23       Impact factor: 6.625

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.